[
  {
    "question": "How is HIV diagnosed?",
    "answer": "HIV diagnosis typically involves a combination of clinical evaluation, laboratory tests, and sometimes additional confirmatory tests. The standard approach includes:\n\n1. **Initial Screening Test**: An HIV antibody test (usually a rapid test or an enzyme immunoassay, EIA) that detects the presence of antibodies against HIV in the blood. This test can be done on blood from a vein or a finger prick.\n\n2. **Confirmatory Test**: If the initial test is positive, a confirmatory test is performed. This is often a more specific test like the Western Blot or an HIV-1/HIV-2 antibody differentiation assay to confirm the diagnosis and sometimes to differentiate between HIV-1 and HIV-2.\n\n3. **Viral Load Test**: After diagnosis, a viral load test (which measures the amount of HIV RNA in the blood) is used to monitor the progression of the disease and the effectiveness of treatment.\n\n4. **CD4 Cell Count**: This test measures the number of CD4 T cells in the blood, which helps assess the immune system's health and guides treatment decisions.\n\nIt's crucial that testing is performed by a healthcare professional and interpreted in the context of clinical symptoms and risk factors. Counseling before and after testing is also an essential part of the process.",
    "true_answer": "HIV is diagnosed through HIV testing. There are three types of tests used to diagnose HIV infection: antibody tests, antigen/antibody tests, and nucleic acid tests (NATs). How soon each test can detect HIV infection differs, because each test has a different window period. The window period is the time between when a person may have been exposed to HIV and when a test can accurately detect HIV infection. Window periods for different HIV tests are the followings: Antibody tests can usually detect HIV 23 to 90 days after exposure. Most rapid tests and self-tests are antibody tests. A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure. An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A NAT can usually detect HIV 10 to 33 days after exposure. When an HIV test is positive, a follow-up test will be conducted for confirmation. Sometimes people will need to visit a health care provider to take a follow-up test using another blood sample. Other times, the follow-up test may be performed in a lab using the original blood sample to ensure that the first positive result wasn\u2019t a false positive"
  },
  {
    "question": "What are the different stages of HIV?",
    "answer": "The different stages of HIV are:\n\n1. **Acute HIV Infection**: The initial stage, occurring 2-4 weeks after infection, where the virus replicates rapidly and the person may experience flu-like symptoms.\n2. **Clinical Latency**: A period where the virus is still active but at low levels, and the person may not show symptoms. This stage can last for years.\n3. **Symptomatic HIV**: As the virus progresses, the person may start experiencing symptoms such as weight loss, fever, and swollen lymph nodes.\n4. **AIDS (Acquired Immunodeficiency Syndrome)**: The most advanced stage, where the immune system is severely damaged, and the person is susceptible to opportunistic infections and certain cancers.\n\nNote: With effective antiretroviral therapy (ART), many people living with HIV can suppress the virus and prevent progression to AIDS.",
    "true_answer": "The different stages of HIV are either defined as three: (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS); or four: (1) acute HIV infection, (2) asymptomatic stage, (3) symptomatic HIV, and (4) Late-stage HIV or AIDS."
  },
  {
    "question": "How is HIV transmitted?",
    "answer": "HIV (Human Immunodeficiency Virus) is primarily transmitted through:\n\n1. Unprotected sexual contact with an infected person (vaginal, anal, or oral sex).\n2. Sharing needles or syringes contaminated with infected blood.\n3. Mother-to-child transmission during pregnancy, childbirth, or breastfeeding (without proper prevention measures).\n4. Blood transfusions from an infected donor (rare in countries with strict blood screening).\n\nIt's not transmitted through casual contact, such as hugging, kissing, or sharing food and drinks.",
    "true_answer": "HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It can also spread from a mother to her baby."
  },
  {
    "question": "What comorbidities are common among people living with HIV?",
    "answer": "People living with HIV often experience various comorbidities, including:\n\n1. Hepatitis B and C coinfections\n2. Tuberculosis\n3. Mental health issues (depression, anxiety)\n4. Cardiovascular disease\n5. Chronic kidney disease\n6. Osteoporosis\n7. Certain cancers (e.g., Kaposi's sarcoma, lymphoma)\n8. Neurocognitive disorders\n9. Lipodystrophy and metabolic syndrome\n\nThese comorbidities can be related to the HIV infection itself, antiretroviral therapy (ART) side effects, or other factors such as lifestyle and socioeconomic status. Regular monitoring and management of these comorbidities are crucial for overall health and well-being.",
    "true_answer": "The most common comorbidities amongst patients with HIV include: diabetes mellitus, cardiovascular disease (CVD, e.g. hypertension), respiratory diseases (e.g. chronic obstructive pulmonary diseases and pneumonia), and hepatic diseases (hepatitis B and C). Liver disease, renal disease, substance dependence and abuse, sexually transmitted infections (herpes simplex, syphilis, gonorrhoea and Mycoplasma genitalium) and psychiatric disorders (including depression, anxiety, schizophrenia and cognitive impairment) are also greater among HIV-positive individuals."
  },
  {
    "question": "How can HIV be prevented?",
    "answer": "HIV prevention methods include:\n\n1. **Using condoms** consistently and correctly during sex.\n2. **Pre-exposure prophylaxis (PrEP)**: taking daily medication for individuals at high risk.\n3. **Post-exposure prophylaxis (PEP)**: taking medication within 72 hours after potential exposure.\n4. **Getting tested** regularly to know your status and that of your partner(s).\n5. **Avoiding sharing needles** or equipment for injecting drugs.\n6. **Taking antiretroviral therapy (ART)** if you're HIV-positive, to reduce viral load and prevent transmission to others.\n7. **Male circumcision** has also been shown to reduce the risk of HIV acquisition in men.\n\nThese methods can significantly reduce the risk of HIV transmission.",
    "true_answer": "HIV prevention involves several key strategies. To reduce the risk of getting HIV, it is important to use condoms correctly every time during sex. For individuals who inject drugs, avoiding drug use altogether is recommended, but if drugs are used, only sterile injection equipment and water should be used, and equipment should never be shared with others. Pre-exposure prophylaxis (PrEP) is an option for those at risk of HIV, involving either a daily HIV medicine or an injectable HIV medicine every two months to lower the risk of infection through sex or injection drug use. For those already living with HIV, taking antiretroviral therapy (ART) as prescribed can reduce the amount of HIV in the blood to undetectable levels, preventing transmission to sexual partners. To prevent perinatal transmission, individuals with HIV who take HIV medicine as prescribed throughout pregnancy and childbirth reduce the risk of passing HIV to their baby to less than 1%. Additionally, in cases where one partner has HIV, PrEP can help protect both the individual and their baby while trying to conceive, during pregnancy, or while breastfeeding."
  },
  {
    "question": "How frequently ART must be taken?",
    "answer": "Antiretroviral therapy (ART) typically needs to be taken daily, with most regimens requiring one or more pills to be taken at the same time every day, often with or without food, depending on the specific medication. Adherence to the prescribed regimen is crucial to effectively manage HIV and prevent drug resistance.",
    "true_answer": "Antiretroviral therapy (ART) must be taken as a pill every day or as a shot once every month or two months."
  },
  {
    "question": "How can we prevent Perinatal transmission of HIV?",
    "answer": "Preventing perinatal transmission of HIV involves several steps:\n\n1. **HIV testing**: All pregnant women should be tested for HIV.\n2. **Antiretroviral therapy (ART)**: HIV-positive pregnant women should start ART as soon as possible to suppress the virus.\n3. **Viral load monitoring**: Regular monitoring of viral load to ensure it remains undetectable.\n4. **Scheduled cesarean delivery** (if viral load is not well-controlled).\n5. **Avoid breastfeeding** (if safe alternatives are available).\n6. **Post-exposure prophylaxis (PEP)**: Administering antiretroviral medication to the newborn within 6-12 hours of birth.\n\nThese measures can reduce the risk of perinatal transmission to less than 1%.",
    "true_answer": "To prevent perinatal transmission of HIV, pregnant women should take antiretroviral therapy (ART) throughout pregnancy and childbirth. ART throughout pregnancy and childbirth reduces the chances of perinatal transmission of HIV to less than 1%."
  },
  {
    "question": "What are the main cell types infected with HIV?",
    "answer": "The main cell types infected with HIV are:\n\n1. CD4+ T cells (also known as T helper cells)\n2. Macrophages\n3. Dendritic cells\n\nThese cells all have CD4 receptors on their surface, which HIV uses to gain entry into the cells.",
    "true_answer": "The main cell types found to be infected with HIV are CD4+ T lymphocytes and macrophage-lineage cells."
  },
  {
    "question": "What is the difference between HIV and AIDS?",
    "answer": "HIV (Human Immunodeficiency Virus) is the virus that attacks the body's immune system, while AIDS (Acquired Immune Deficiency Syndrome) is the most advanced stage of HIV infection. \n\nIn other words, HIV is the virus itself, and AIDS is the condition that occurs when the virus has severely damaged the immune system, making the person more susceptible to opportunistic infections and certain cancers. Not everyone with HIV will develop AIDS, especially with proper treatment and care.",
    "true_answer": "HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. AIDS stands for acquired immunodeficiency syndrome, the most advanced stage of HIV infection."
  },
  {
    "question": "How is HIV not transmitted?",
    "answer": "HIV is not transmitted through:\n\n* Casual contact, such as hugging, shaking hands, or sharing food and drinks\n* Air or water\n* Insect bites\n* Saliva, sweat, or tears, unless they are mixed with blood of an infected person\n* Toilet seats, doorknobs, or other surfaces\n* Sharing personal items like towels, razors, or toothbrushes, unless they are contaminated with blood\n\nIt's also important to note that HIV cannot be transmitted through everyday social interactions or by being around someone with HIV.",
    "true_answer": "You cannot get HIV from: Air or water. Saliva, tears, sweat, feces, or urine that is not mixed with the blood of a person with HIV. Casual contact with a person who has HIV, such as a handshake, a hug, or a closed-mouth kiss. Contact with objects, such as toilet seats, doorknobs, or dishes used by a person who has HIV. Mosquitoes, ticks, or other biting insects. Other sexual activities that do not involve the exchange of body fluids (for example, touching). HIV can\u2019t be passed through healthy, unbroken skin."
  },
  {
    "question": "What is known about the switch that occurs between patients with latent HIV and active infection?",
    "answer": "The switch from latent HIV to active infection is a complex process, not fully understood. However, it's known that latency is characterized by a state of transcriptional silence, where the virus is not actively replicating. \n\nThe switch to active infection is thought to be triggered by various factors, including:\n\n1. Cellular activation: When latently infected cells, such as memory T cells, are activated, they can begin to express viral genes, leading to viral replication.\n2. Epigenetic changes: Modifications to the viral genome or host chromatin can influence the transition from latency to active infection.\n3. Inflammatory signals: Cytokines and other inflammatory mediators can reactivate latent HIV.\n\nResearch is ongoing to understand the molecular mechanisms underlying this switch, with the goal of developing strategies to prevent or reverse latency.",
    "true_answer": "The switch between latent and active HIV infection is primarily driven by the activation of HIV provirus within latently infected cells. Latent HIV infection occurs when the virus integrates its genetic material into the host cell's DNA, allowing the virus to persist in a dormant state. In latent infection, viral replication and gene expression are minimal or absent, and the infected cells remain functionally normal. This form of infection is responsible for the long-term persistence of HIV in individuals, even when systemic viral replication is suppressed with antiretroviral therapy (ART). The switch to active HIV infection occurs when the provirus becomes transcriptionally active; this is often triggered by extracellular signals or events that activate the host cell . One possible mechanism for the switch involves the binding of cellular transcription factors, such as nuclear factor kappa B (NF-\u03baB) and nuclear factor of activated T-cells (NFAT), to the HIV long terminal repeat (LTR) region, resulting in the activation of proviral transcription. Other factors that can contribute to the switch include cytokines, chemokines, and cellular activation signals. This transition between latent and active HIV infection plays a critical role in the pathogenesis of the disease, as it is during periods of active infection that the virus replicates and spreads to new cells, ultimately leading to the progressive decline of the host immune system . Understanding the molecular mechanisms involved in the switch from latent to active HIV infection could help inform the development of novel therapeutic strategies aimed at targeting and eliminating latently infected cells, which represent a major obstacle to achieving a cure for HIV."
  }
]